McKesson Corporation’s Medical-Surgical Solutions (MMS) unit priced a $2.25 billion leveraged loan on June 3, 2026.
The financing establishes an independent capital structure for the business ahead of a planned initial public offering.
This move follows the recent operational and legal separation of the MMS business from its parent company.
MMS will use the proceeds to satisfy existing intercompany agreements with McKesson.
The transaction supports the broader strategy to transition the unit into a standalone, publicly traded company.